Learn More
ATCC BCL2 Jurkat; Acute T Cell Leukemia; Human (Homo sapiens)
Supplier: ATCC CRL2899

BCL2 Jurkat is a T lymphocyte cell line that was isolated in 2003 from the peripheral blood of a 14-year-old, male patient with leukemia, acute T cell. It was derived by transfecting the human Jurkat T cells with the pSFFV-neo mammalian expression vector containing the human BCL-2 ORF insert and a neomycin-resistant gene. This cell line was deposited by Stanley Korsmeyer and can be used in immunology and immune system disorder research.
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.